Motilal Oswal S&P BSE Healthcare ETF - Growth - Regular Plan

  • Previous Nav

  • Net Change on 29-05-2024

  • PersonalFN Rating

  • Category

  • Assets (Cr.)

  • Expense Ratio

Fund Overview Growth | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
S&P BSE Health Care - TRI 0.32 1.71 52.41 14.18 22.63 15.27

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Nifty 50 ETF Jul 22, 2015 25.09 15.34 15.12 0.04 179,764.58
SBI S&P BSE SENSEX ETF Mar 15, 2013 21.83 14.86 14.88 0.04 109,812.59
UTI Nifty 50 ETF Sep 01, 2015 25.10 15.35 15.12 0.05 51,391.10
UTI S&P BSE Sensex ETF Sep 01, 2015 21.83 14.87 14.88 0.05 39,377.65
Nippon India ETF Nifty 50 BeES Dec 28, 2001 25.12 15.37 15.16 0.04 24,792.90

Fund Holdings as on 30-April-2024

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Dr. Reddy's Laboratories Limited

  • Max Healthcare Institute Limited

  • Apollo Hospitals Enterprise Limited

  • Divi's Laboratories Limited

  • Lupin Limited

  • Aurobindo Pharma Limited

  • Zydus Lifesciences Limited

  • Torrent Pharmaceuticals Limited

  • Fortis Healthcare Limited

  • IPCA Laboratories Limited

  • Laurus Labs Limited

  • Alkem Laboratories Limited

  • Glenmark Pharmaceuticals Limited

  • Abbott India Limited

  • JB Chemicals & Pharmaceuticals Limited

  • Biocon Limited

  • Global Health Limited

  • Syngene International Limited

  • Gland Pharma Limited

  • Krishna Institute Of Medical Sciences Limited

  • Ajanta Pharma Limited

  • Natco Pharma Limited

  • GlaxoSmithKline Pharmaceuticals Limited

  • Narayana Hrudayalaya Limited

  • Piramal Pharma Limited

  • Dr. Lal Path Labs Limited

  • Sanofi India Limited

  • Mankind Pharma Limited

  • Poly Medicure Limited

  • Rainbow Childrens Medicare Limited

  • Suven Pharmaceuticals Limited

  • Pfizer Limited

  • Neuland Laboratories Limited

  • Aster DM Healthcare Limited

  • Strides Pharma Science Limited

  • Granules India Limited

  • Alembic Pharmaceuticals Limited

  • Net Receivables / (Payables)

  • Jubilant Pharmova Limited

  • Metropolis Healthcare Limited

  • Marksans Pharma Limited

  • Procter & Gamble Health Limited

  • Eris Lifesciences Limited

  • Wockhardt Limited

  • AstraZeneca Pharma India Limited

  • Vijaya Diagnostic Centre Limited

  • Caplin Point Laboratories Limited

  • Aarti Pharmalabs Limited

  • Concord Biotech Limited

  • FDC Limited

  • Shilpa Medicare Limited

  • Unichem Laboratories Limited

  • Kovai Medical Center and Hospital Limited

  • Advanced Enzyme Technologies Limited

  • Ami Organics Limited

  • Sun Pharma Advanced Research Company Limited

  • Glenmark Life Sciences Limited

  • Aarti Drugs Limited

  • Dishman Carbogen Amcis Limited

  • Sequent Scientific Limited

  • Healthcare Global Enterprises Limited

  • Morepen Laboratories Limited

  • Indoco Remedies Limited

  • Hikal Limited

  • Jupiter Life Line Hospitals Limited

  • Indraprastha Medical Corporation Limited

  • Supriya Lifescience Limited

  • Krsnaa Diagnostics Limited

  • Thyrocare Technologies Limited

  • Solara Active Pharma Sciences Limited

  • IOL Chemicals and Pharmaceuticals Limited

  • Gufic Biosciences Limited

  • Shalby Limited

  • Gujarat Themis Biosyn Limited

  • Novartis India Limited

  • Yatharth Hospital And Trauma Care Services Limited

  • Suven Life Sciences Limited

  • Tarsons Products Limited

  • Bliss GVS Pharma Limited

  • Syncom Formulations India Limited

  • RPG Life Sciences Limited

  • Blue Jet Healthcare Ltd

  • Themis Medicare Limited

  • Hester Biosciences Limited

  • Lincoln Pharmaceuticals Limited

  • Kopran Limited

  • Artemis Medicare Services Limited

  • SMS Pharmaceuticals Limited

  • Sigachi Industries Limited

  • Innova Captab Limited

  • NGL Fine Chem Limited

  • Vimta Labs Limited

  • KMC Speciality Hospitals (India) Limited

  • MEDICAMEN BIOTECH LIMITED

  • Bajaj Healthcare Limited

  • Jagsonpal Pharmaceuticals Limited

  • Sastasundar Ventures Limited

  • Panacea Biotec Limited

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Business Support

  • Medical Equipment/Supplies/Accessories

  • Miscellaneous

  • Plastic Products

  • Trading

  • Chemicals

  • Finance - NBFC

View More

Fund Manager

  • Cash

  • Equity

View More

About Motilal Oswal S&P BSE Healthcare ETF

Scheme Analysis

Motilal Oswal S&P BSE Healthcare ETF is a ETFs - Index fund and belongs to Motilal Oswal Mutual Fund. It was launched on 29-Jul-2022 and currently has an AUM of ₹13.07 crore. Motilal Oswal S&P BSE Healthcare ETF is benchmarked against S&P BSE Health Care - TRI as primary index.

The NAV of Motilal Oswal S&P BSE Healthcare ETF ended up ₹0.11(0.3%)yesterday to ₹35.9103.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Motilal Oswal S&P BSE Healthcare ETF is managed by Swapnil P Mayekar and Rakesh Shetty.

Fund House Contact

10th Floor, Motilal Oswal Tower, Rahimtullah Sayani Road, Opp Parel ST Bus Depot, Prabhadevi Mumbai - 400025

022-39804238
022-22816161